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TIME-DOSAGE RELATIONSHIP IN THE TREATMENT OF TREP-
ONEMAL DISEASES WITH A NEW COMBINATION OF THREE
PENICILLIN SALTS. LABORATORY AND CLINICAL BASIS FOR
EFFECTIVE THERAPY.*
C. R. RSIN, M.D., F. H. BUCKWALTER, M.S., C. H. MANN, M.D.,
S. E. LANDY, M.D. AND S. FLAX, B.A.
This study t deals with the evaluation of a new combination of three penicillin
salts in the treatment of treponemal diseases. This combination was so formu-
lated as to provide 300,000 units of buffered potassium penicillin G, 300,000 units
of procaine penicillin G and 600,000 of N, N' dibenzylethylenediamine dipeni-
cihin G as an aqueous suspension in a 2 ml. quantity. The product is not new in
the sense that the three penicillin salts included in the formulation are untried in
medical practice. It was conceived by Buckwalter on the basis that the solubility
variations of each penicillin salt when administered as a single intramuscular
injection should provide an initial high blood concentration within one hour due
to the rapid solubility and absorption of the potassium penicillin G, an inter-
mediate blood concentration for 24 to 36 hours due to the less soluble procaine
penicillin G, and finally a prolonged blood concentration for at least 15 days or
longer in the majority of patients due to the relative insolubility of N, N' di-
benzylethylenediamine dipenicillin G.
A repository penicillin formulation of this type should be of great value in the
treatment of treponemal diseases particularly of the nonvenereal types where
there may be considerable secondary infection. It is specially indicated in those
countries where the majority of the patients must be treated with single injection
schedules in rural areas. The high initial level and the prolonged low but adequate
level obtained with this combination should make it extremely efficacious in the
treatment of gonorrhea when a concomitant syphilis infection is suspected.
During a study of the properties of certain penicillin salts, Szabo, Edwards and Bruce
(1) discovered that the coupling of N,N' dibenzylethylenediamine with penicillin resulted
in the formation of a new complex in which one molecule of the base combined with two
molecules of penicillin. Its outstanding property is the very low solubility in water of only
200 units per ml.
Seifter, Glassman, Begany and Blumenthal (2) investigated the toxicity of this com-
pound and found it to be approximately 25 per cent more toxic than procaine penicillin by
intraabdominal injection in mice, but was not more toxic when administered by intragastric
drip. It produced less nausea and vomiting by intragastric administration in dogs. It was
no more irritating than procaine penicillin to ocular mucosae, skin and muscle. When in-
* From the Department of Dermatology and Syphilology of the New York University
Post-Graduate Medical School and the Skin and Cancer Unit of the New York University
Hospital (Dr. Marion B. Sulzberger, Chairman) and from the Bristol Laboratories, Inc.,
Syracuse, N. Y.
Read before the Fourteenth Annual Meeting of the Society for Investigative Dermatol-
ogy, Inc., May 30—31, 1953, New York, N. Y.
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jected intramuscularly in man, Elias, Price and Merrion (3) found that it compared favor-
ably to procaine penicillin with respect to toxicity. In a more recent study by Fletcher and
Knappet (4) a series of 19 volunteer male subjects received a single injection of one ml.,
containing 600,000 units of this penicillin complex, in the gluteal muscles. Most of the sub-
jects complained of aching at the injection site for 24 to 48 hours, but in no instance was this
severe. One subject developed a "serum sickness" reaction ten days after the injection.
Smith in a recent report before the American Venereal Disease Association stated that
the incidence of reaction among 1,377 patients receiving from 300,000 to 2,500,000 units of
N, N' dibenzylethylenediamine dipenicillin G was less than 0.3 per cent.
Pharmacologically, the triple penicillin combination may be assessed on the
basis of the extensive reports that have been published on each of the three salts
of penicillin contained in this product. The monograph describing this combina-
tion product was published in the March 30, 1953 issue of the Federal Register.
It has been added to the list of certifiable antibiotics, the control of which comes
under the jurisdiction of the Food and Drug Administration.
MATERIALS AND METHODS
The combination of the three penicillin salts* was supplied in a dry powder
form which is stable for at least 24 months at room temperature. It is reconsti-
tuted in the vial prior to use with 6.5 ml. of distilled water to provide a volume
sufficient for the withdrawal of five separate 2 ml. doses. After reconstitution,
full potency is maintained for one week under refrigeration. These doses are
easily withdrawn from the vial and injected into the gluteal muscle with a
inch 19 gauge needle. A shortened name for this formulation "Panbiotic" will be
used in this communication.
A total of 94 male and female subjects took part in this investigation. A few
were ultimately excluded because they inadvertently received penicillin during
the course of the study or because they were subjected to extensive surgical
procedures which made it impossible to obtain repeated blood samples for
penicillin assay. Control samples of blood were collected before the injection and
consecutive samples were taken at the intervals indicated in the charts.
Penicillin assays were performed by the cup-plate method employing the
test organism, Sarcina lutea. In a previous study (6) this microbiologic procedure
was found to be the most accurate and reproducible method for the determination
of penicillin in serum. The undiluted serum to be assayed is placed on a solid
agar seeded plate in penicylinders under standard conditions. If soluble and
readily absorbed penicfflin salts are being assayed, it is preferable to make five,
ten, or twenty-fold dilutions in gelatin prior to testing in order to obtain a more
accurate determination of the end-point in the inhibition of the bacterial growth.
The zone of inhibition or no growth is measured and calculations are made which
determine the unitage strength of the serum being tested. A complete set of con-
trol plates is run with each set of serum assays.
*
"Parthiotic" was supplied in five dose vials containing 6,000,000 units of total penicillin
or 1,200,000 units per 2 ml. dose.
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RESULTS
Chart 1 records the status, sex, race, age and weight of each subject with blood
penicillin levels obtained before and at various intervals following a single in-
jection. It will be noted that average blood concentrations of 3.185 units of
penicillin per ml. at one hour, 0.281 units at 12 hours, 0.198 units at 24 hours and
0.023 at 360 hours were obtained after a single injection.
Chart 2 presents a fitted semiogarithmic curve of average penicillin blood
concentrations in the 50 subjects injected with a single dose of 2 ml. containing
1,200,000 of the triple combination of penicillin salts.
Chart 3 is a composite fitted semilogarithmic presentation comparing the
average penicillin blood concentrations obtained in 18 subjects following a single
injection of 4 ml. (1,200,000 units) of procaine penicillin G in oil jelled with 2
per cent aluminum morrostearate (Flociffin "96") and 20 subjects receiving a
single injection of 600,000 units of N, N' dibenzylethylenediamine dipenidilin
G (Wyeth) with the 50 subjects following a single injection of 2 ml. (1,200,000
units) of Panbiotic. It will be noted that higher and more prolonged levels are
obtained with Panbiotic at the one, 12, and 24 and 360 hour intervals than with
the two other penicillin preparations.
A study was designed to determine whether it would be possible to maintain
high peak blood concentrations following a single daily injection for five days of
the triple penicillin formulations and to observe any untoward effects from this
schedule. Seventeen patients were selected for this study, of which fifteen were
available for the entire evaluation. Control specimens of blood were collected
prior to the first injection. Each subject received a single injection of 2 ml. of
Panbiotic in the gluteal muscles once a day for five consecutive days. Blood
specimens were collected one hour after each injection and at consecutive inter-
vals as indicated on the chart for a total of 1152 hours (48 days).
Chart 4 records the status, sex, race, age and weight of the 15 subjects with
blood penicillin levels obtained one hour after each injection. It will be noted
that high concentration peaks of penicillin were assayed during this five day
period and that the general trend suggests a cumulative effect.
Chart 5 records the blood penicillin concentrations obtained in each subject
beginning one hour after the fifth consecutive daily injection and followed at
various intervals through a period of 1152 hours (48 days). It will be noted that
3 of the 4 patients tested showed assayable levels 48 days after the last injection.
A series of 54 patients with a variety of pustular skin diseases was selected to
determine the incidence of pain or discomfort following an intramuscular injec-
tion of Panbiotic. Each patient received 2 ml. (1,200,000 units) of this prepara-
tion in one buttock. As stated previously this amount contained 600,000 units
of N, N' dibenzylethylenediamine dipenicilin G. At the same time an injection
of one or two ml. of Bicilin (Wyeth) containing 600,000 units of N, N' dibenzyl-
ethylenediamine dipenicfflin G was injected in the other buttock. These patients
were examined and questioned three to seven days following the injections. In
six patients there was no discomfort or untoward local reaction with either
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CHART 4
Penicillin blood concentrations in 15 patients receiving a daily i.m. dose ( cc) for 5 consecutive
days of the new triple penicillin preparation
NO. STATUS SEX RACE AGE w'r. 0 1-1 2-1 3-1 4-1 .5-1
80 A F W 54 160 Neg. 2.25 4.75 6.63 3.43 5.48
98 A M C 49 149 Neg. 2.40 4.40 2.53 3.30 3.20
100 A M W 54 130 Neg. 2.65 2.25 2.95 3.70 7.1596 W M W 20 130 Neg. 2.85 3.80 2.60 3.60 4.8599 W M W 43 130 Neg. 3.00 3.80 2.55 4.25 4.35103 A M C 34 178 Neg. 3.60 2.00 3.30 3.55 4.60
95 B M C 50 130 Neg. 3.75 4.15 4.70 3.90 5.25108 A M W 65 162 Neg. 3.90 3.40 2.60 6.40 5.20104 A M W 70 167 Neg. 3.95 3.83 2.35 3.80 4.8597 A M W 57 140 Neg. 4.00 4.50 7.50 5.00 7.75
107 A M W 80 200 Neg. 4.05 7.25 5.63 5.88106 A M C 39 142 Neg. 4.93 3.95 3.83 3.25 3.80
101 A M W 52 163 Neg. 5.00 5.25 5.50 2.88 4.53
105 A M W 74 127 Neg. 5.20 4.80 4.65 4.60 3.68102 A M C 38 160 Neg. 5.25 3.15 6.60 2.83 4.50
Average 3.79 4.09 4.26 3.89 5.00
CHART 5
Penicillin blood concentrations in 15 patients at various intervals of time following the 5th
consecutive daily cc i.m. injection of the new triple penicillin combination
1D 4D 1OD 1SD 2iD 241) 311) 34D 38D 411) 481)
NO. 5-1 24 96 240 360 304 576 744 816 912 984 1152
98 3.20 .25 .11 .13 .09 .07 .04
105 3.68 .17 .19 .12 .17 .11 .06
106 3.80 .31 .27 .13 .10 .06 .04 .03 00 00
99 4.35 .37 .26 .12 .08
102 4.50 .27 .19 .10 .10
101 4.53 .43 .22 .11 .12 .09 .10
103 4.60 .28 .14 .14 .06
104 4.85 .65 .21 .17 .10
96 4.85 .21
108 5.20 .78 .33 .22 .14
95 5.25 .35 .34 .10 .10 .13 .06 .04
80 5.48 .25 .16 .12 .10 .09 .05
107 5.88 .64 .19 .44 .21 .18 .13 .10
100, 7.15 .54 .25 .22 .12 .08 .04
97 7.75 .49 .29 .13 .14 .11 .10 .06 .05
Average 5.00 .399 .225 .165 .116 .101 .081 .03 .08 .06 .05 .032
product. Eight patients complained of some, but equal, discomfort with both
preparations. Fourteen patients experienced no pain with Panbiotic and moder-
ate to marked pain with Biciffin. In the remaining 26 patients there was local
TREATMENT OF TREPONEMAL DISEASES WITH PENICILLIN SALTS 443
tenderness following both injections, but much more with the Bicillin than with
the Panbiotic. In most instances the pain persisted for 2 to 5 days. Two patients
developed generalized urticaria ten days after the injections of Panbiotic and
Bidillin and one patient had a similar urticarial eruption within 2 hours after the
double injection. In 94 subjects who received single or multiple injections of
Panbiotic for assay studies in the hospital, there were no instances of urticaria
or other untoward reactions.
DISCUSSION
The new penicillin combination reported in this communication would appear
to be more desirable for the treatment of treponemal diseases than the previously
available repository forms for the following reasons:
(1) Physical Properties. Aqueous suspension freely syringeable. High dose
(1,200,000 units) in low volume (2 ml.).
(2) Blood Concentrations of Penicillin. High initial concentrations (within one
hour). Sustained intermediate concentrations (24 to 36 hours). Prolonged con-
centrations (at least 15 days or longer in the majority of patients).
Repository penicillin of this type should be of utmost value in the treatment
of treponemal diseases in underprivileged countries where the majority of pa-
tients must be treated in the shortest period of time and on an ambulatory basis
in rural clinics. The optimal form of therapy appears to be with a single injection
of penicillin. In this manner 100 per cent of those reporting for treatment would
receive and complete therapy in a "single treatment". Studies are now under
way in various parts of the world to evaluate this penicillin formulation in the
therapy of syphilis, yaws and pinta. Preliminary clinical data are highly en-
couraging.
CONCLUSIONS
1. A new combination of three penicillin salts is described. A single dose of
2 ml. in aqueous suspension provides 300,000 units of potassium penicillin G,
300,000 units of procaine peniciffin G and 600,000 units N, N' dibenzylethylene-
diamine dipenicfflin G. Microbiologic assay determinations indicate that higher
and more prolonged blood levels are obtained with a single injection of 2 ml.
of this material than with a single injection of 4 ml. of microcrystalline penicillin
G jelled in oil with 2 per cent aluminum monostearate, even though both contain
1,200,000 units of penicillin.
2. Initial clinical trials in syphilis, yaws and pinta are highly encouraging.
Furthermore, an adequate amount of therapy can be administered in a single
injection without fear of any increased evidence of serious untoward reactions.
3. This type of penicillin preparation should be of special value in those coun-
tries where the majority of the patients must be treated with single injection
schedules in rural areas.
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DISCUSSION
DR. D. K. KITCHEN, New York City, N. Y.: I am particularly proud to be
among those who have been congratulating these workers on having formulated
this product and having done this excellent study on the concentration of peni-
cillin produced in serum following its single injection. A few years ago, with a
schedule of penicillin that was necessarily given at two hour intervals (devised
by Mahoney and his workers), we have now arrived at a point where a single
injection of this new material will exert a high, profound and prolonged serum
concentration to an extent of 21 or more days. This marks about the first time,
to my knowledge at least, that we have been able to produce a repository deposi-
tion of material remotely similar to this.
A number of things are interesting here. In the first place the dibenzyl portion
of the salt has produced no irritation. I would like also to call your attention to
the fact that the extremely high concentrations of from three, four, five, six to
seven units per cc. are very difficult to attain or to maintain with any type of
penicillin unless it is administered by the intravenous route or in extremely high
doses intramuscularly. As Dr. Rein has pointed out, the implications of this
prolongation in serum concentration in the treatment of treponemal diseases
is extremely important, particularly in the light of the eradication programs now
going forward by WHO and the Pan-American Sanitary Bureau and others in
such conditions as syphilis, pinta and yaws, bejel, etc.
The implications from this report go further than the treatment of treponemal
diseases. We have seen probably for the first time an instance where a single
treatment of the material is effective over a long enough period of time to be
possibly effective in diseases such as subacute bacterial endocarditis (where
perhaps the level should be a little higher but where the extent of the level cer-
tainly would be of value) and acute rheumatic fever. The implication of using this
material in treating many diseases where there is little likelihood of seeing the
patient more than once or a few times is obvious.
DR. BERNARD FISHER, Sydney, Australia: I would like to ask Dr. Rein, if he
has had any experience in the use of triple penicillin for acne. We know that
penicillin therapy is one of the many methods used in the treatment of acne,
with varying results. However I find that relapse following penicillin treatment
is often severe and that there are difficulties involved in treating some patients
for long periods of time.
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DR. IRA L. SCHAMBERO, Philadelphia, Pa.: I would like to congratulate Dr.
Rein on his, as usual, dynamic presentation. I have three questions. The first
concerns the name "Panbiotic." I think it would suggest to many people a com-
bination of all of the increasing number of different antibiotics, and would not
indicate that this preparation is solely penicillin.
The second question concerns the chart which shows a higher blood level for
Panbiotic than for Bidillin from the 9th day on. I cannot understand why Bicillin
showed so much lower a level at 15 days than did Panbiotic.
Thirdly, Dr. Harry Eagle's work has shown the marked sensitivity of the
treponema to penicillin. It is the most sensitive of all organisms. Dr. Eagle
has also shown that increasing the concentration of penicillin beyond certain
rather narrow limits does not increase treponemacidal activity. I can see very
clearly that for many bacterial diseases, and as Dr. Rein suggested, for secondar-
ily infected yaws, a high early level such as Panbiotic provides would be of
value; but I am wondering, on the basis of what we know about treponemacidal
activity from Dr. Eagle's work, whether there is any theoretical basis for feeling
that this high early concentration would bring about better results in syphilis
than does the lower blood level provided by Biciffin alone.
DR. HERMAN BEERMAN, Philadelphia, Pa.: I would like to call attention to the
fact that this is the Society for Investigative Dermatology but whose constitution
in Article II says, "The objects of this corporation are to conduct, promote,
encourage, assist investigation, research in medicine and surgery and more
particularly in dermatology and syphilology." I am not here to make another
appeal such as I made in 1946, when I was President of this organization, for
more study of the subject of syphilis, but I do believe that we are now on the
verge of an important upswing in the incidence of syphilis rather than a decrease
of such extent that we should avoid further study of this treponemal disease.
According to our constitution, Dr. Rein's paper should have received, instead of
ten minutes, half of our program time, since it is the only presentation on our
program dealing with syphilis.
In connection with the content of Dr. Rein's excellent paper, I would like to
point out that we should not be too enthusiastic about a drug because of its
abifity to produce high blood levels. I believe that we are becoming a little too
lax in our interpretation of what a good antisyphiuitic agent is by so-called rapid
fire, short term evaluations. I stifi believe that time is the essence of the evaluation
of antisyphilitic agents.
DR. CHARLES R. REIN (in. closing): I wish to thank the discussors, especially
Dr. Kitchen, for their kindness and constructive criticism. I should like to report
on a patient with actinomycosis who received daily injections of this preparation
for a total of 30 million units during a period of 18 days with a dramatic and
rapid healing of the lesions. Penicillin was still detected by blood assay 65 days
(1560 hours) following the last injection. His level at that time was 0.04 units/
ml. These large doses of 4 ml. daily produced no pain, discomfort or allergic
reactions.
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In answer to Dr. Fisher, we have used this preparation in the treatment of
acne vulgaris with good results as far as the pustular elements are concerned.
Equally good results have been obtained by others who have used similar long
acting repository penicillin preparations. Injections of 600,000 units at one to
two week intervals may be sufficient to keep the secondary pustular activity
under control.
I agree with Dr. Schamberg that the long acting penicillin salt is in itself
adequate for the treatment of syphilis. But in those treponemal diseases, espe-
cially yaws and bejel, where there may be considerable secondary infection, a
preparation of this type composed of three penicillin salts may be preferable since
it provides for a high level of penicillin as well as the prolonged low level with a
single injection.
